Eevia being followed by Analyst Group

Analyst Group Initiates equity research Coverage of Eevia Health Plc, (”Eevia” or ”The Company”). The financial analyst Rosan Tekin and the equity research firm Analyst Group started tracking Eevia and issued a first equity analysis report last week. The report can be found here. Analyst Rosan Tekin summarized the investment case: “Eevia Health offers organic […]

Read more...


Eevia successfully participates at Vitafoods trade show in Geneva

Eevia Health Plc, (”Eevia” or ”The Company”), is taking part in the trade show “Vitafoods” in Geneva this week (10-12 May 2022). The Vitafoods trade show (www.vitafoods.eu.com)is one of the key trade shows for decision-makers in the global nutraceutical industry. This trade show has a great reputation over decades as a focused and high-quality B2B event, displaying the […]

Read more...

A 3,3 MSEK/0,33 MEUR sales order for bilberry extract

Eevia Health Plc, (”Eevia” or ”The Company”), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania. The sales value […]

Read more...

Eevia Health appoints new distributor

Eevia Health Plc, (”Eevia” or ”The Company”) has appointed Select Ingredients, San Diego, California, USA, as new distributor in the territory of the USA. Eevia Health has appointed Select Ingredients Inc as distributor in the USA. Select Ingredients will focus on organic ingredients for food and supplements applications. The parties will also undertake a joint […]

Read more...


A new sales agreement for specialty plant-based nutraceutical extract worth SEK 8 million

Eevia Health lands a new sales agreement for specialty plant-based nutraceutical extract worth SEK 8 million Eevia Health Plc (“Eevia” or “The Company”), a leading health ingredient manufacturer from Finland, today announces that it has entered a multi-year sales agreement. The sales agreement is with a Finnish customer to supply a specialty protein and fiber […]

Read more...

Eevia Health is welcoming Harri Salo as our new Chief Manufacturing Officer

Eevia Health Plc, (”Eevia” or ”The Company”), is welcoming Harri Salo as our new Chief Manufacturing Officer. Harri Salo has a 15-year strong career in operations and production management in international industrial business environments. He will start Monday, January 10th, and significantly strengthen Eevia Health’s management capacity and competence for developing production organization, operation, and […]

Read more...


Chaga Immune study abstract

Effect of Chaga Mushroom as a Natural Immune Modulator on Upper-Respiratory Tract Infections (URTIs) and Psychological Mood State Eevia Health study conducted in collaboration with Dr. Shawn M. Talbott and GLH Nutrition, November 17, 2021 Background Heavy exercise or intense training may increase susceptibility to upper respiratory tract infections (URTI) (Nieman et al., 1990; Peters […]

Read more...